RecruitingNCT06953622
Establishment of a Clinical and Prognostic Follow-up Cohort of Migraine Patients With Patent Foramen Ovale
Sponsor
Peking University Third Hospital
Enrollment
330 participants
Start Date
Jan 1, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
To establish a headache center in China that combines clinical, imaging and laboratory examinations, explore the feasible treatment options for migraine combined with patent foramen ovale, and search for the possible influencing factors, construct models that influence prognosis.
Eligibility
Inclusion Criteria3
- Meet the diagnostic criteria for migraine in the International Classification of Headache (ICHD-3);
- Confirmation of patent foramen ovale through transthoracic echocardiography(TTE) or transesophageal echocardiography(TEE)/right heart contrast echocardiography
- Agree to participate in the study and sign the informed consent form.
Exclusion Criteria1
- Can not sign the informed consent form or cooperate with follow-up.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGConservative treatment
Receive no antipaletet drug treatment and surgery
DRUGAntipaletet drug
Use of antipaletet drugs.
PROCEDUREPatent Foramen Ovale Closure
Receive the surgery of Patent Foramen Ovale
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06953622
Related Trials
Post-Marketing Study to Assess the Safety and Effectiveness of Oral Atogepant in Korean Adult Participants for the Prevention of Chronic or Episodic Migraine
NCT066035584 locations
Mind Body Balance for Pediatric Migraine
NCT047156852 locations
Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine
NCT06417775106 locations
A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
NCT0516417270 locations
BE WELL With Migraine: Brain Education and WELLness With Migraine
NCT059875923 locations